Beyond pharmacotherapy in IBD: feasibility and patient-reported benefits of a six-week multimodal rehabilitation pilot.

Saved in:
Bibliographic Details
Title: Beyond pharmacotherapy in IBD: feasibility and patient-reported benefits of a six-week multimodal rehabilitation pilot.
Authors: Dermine S; Department of Gastroenterology and Nutritional Support, Center for Intestinal Failure, Reference Center for Rare Diseases MarDI, AP-HP Beaujon Hospital, Paris University, France. Electronic address: solene.dermine@aphp.fr., Bazin T; Department of Gastroenterology and Nutritional Support, Center for Intestinal Failure, Reference Center for Rare Diseases MarDI, AP-HP Beaujon Hospital, Paris University, France; Infection & Inflammation, UMR 1173, Inserm, UVSQ/Paris Saclay University, Montigny-le-Bretonneux, France., Alioui L; Department of Gastroenterology and Nutritional Support, Center for Intestinal Failure, Reference Center for Rare Diseases MarDI, AP-HP Beaujon Hospital, Paris University, France., Lecoq E; Department of Gastroenterology and Nutritional Support, Center for Intestinal Failure, Reference Center for Rare Diseases MarDI, AP-HP Beaujon Hospital, Paris University, France., Jarraya S; Department of Gastroenterology and Nutritional Support, Center for Intestinal Failure, Reference Center for Rare Diseases MarDI, AP-HP Beaujon Hospital, Paris University, France., Billiauws L; Department of Gastroenterology and Nutritional Support, Center for Intestinal Failure, Reference Center for Rare Diseases MarDI, AP-HP Beaujon Hospital, Paris University, France; Gastrointestinal and Metabolic Dysfunctions in Nutritional Pathologies, Inserm UMR 1149, Centre de Recherche sur l'Inflammation Paris Montmartre, France., Bresteau C; Department of Gastroenterology and Nutritional Support, Center for Intestinal Failure, Reference Center for Rare Diseases MarDI, AP-HP Beaujon Hospital, Paris University, France., El Khatib M; Department of Gastroenterology and Nutritional Support, Center for Intestinal Failure, Reference Center for Rare Diseases MarDI, AP-HP Beaujon Hospital, Paris University, France., de Castelbajac F; Department of Gastroenterology and Nutritional Support, Center for Intestinal Failure, Reference Center for Rare Diseases MarDI, AP-HP Beaujon Hospital, Paris University, France., Corcos O; Department of Gastroenterology and Nutritional Support, Center for Intestinal Failure, Reference Center for Rare Diseases MarDI, AP-HP Beaujon Hospital, Paris University, France; Hôpital Bichat, Laboratory for Vascular Translational Science, Paris, France., Nuzzo A; Department of Gastroenterology and Nutritional Support, Center for Intestinal Failure, Reference Center for Rare Diseases MarDI, AP-HP Beaujon Hospital, Paris University, France; Hôpital Bichat, Laboratory for Vascular Translational Science, Paris, France., Joly F; Department of Gastroenterology and Nutritional Support, Center for Intestinal Failure, Reference Center for Rare Diseases MarDI, AP-HP Beaujon Hospital, Paris University, France; Gastrointestinal and Metabolic Dysfunctions in Nutritional Pathologies, Inserm UMR 1149, Centre de Recherche sur l'Inflammation Paris Montmartre, France.
Source: Clinics and research in hepatology and gastroenterology [Clin Res Hepatol Gastroenterol] 2026 May; Vol. 50 (5), pp. 102818. Date of Electronic Publication: 2026 Mar 28.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Masson Country of Publication: France NLM ID: 101553659 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2210-741X (Electronic) Linking ISSN: 22107401 NLM ISO Abbreviation: Clin Res Hepatol Gastroenterol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2210-741X
DOI:10.1016/j.clinre.2026.102818